Dermal extracellular matrix (Dermal ECM) (Dermal ECM)

The dermal extracellular matrix (ECM) is a complex, three-dimensional network of extracellular macromolecules, primarily composed of Type I and Type III collagen, elastin, and proteoglycans, that provides essential structural and biochemical support to the skin (Source: StatPearls, PMID: 30085513). It plays a critical role in maintaining skin elasticity, tensile strength, and facilitating cellular processes such as migration and wound healing (Source: PMC, PMC6010118). In healthy tissue, the ECM is dynamically regulated through a balance of synthesis by fibroblasts and degradation by matrix metalloproteinases (MMPs). In pathological states, the dermal ECM can undergo significant remodeling; for instance, photoaging leads to collagen fragmentation and loss, while fibrotic conditions like keloids involve excessive collagen deposition (Source: Journal of Investigative Dermatology, DOI: 10.1038/jid.2014.226). Therapeutic interventions often target the ECM to either stimulate new collagen synthesis using retinoids or degrade pathological collagen using enzymes like collagenase (Source: FDA, Xiaflex Label). Understanding the dynamic balance between matrix synthesis and degradation is vital for developing treatments for aging, scarring, and chronic wounds (Source: Nature Reviews Molecular Cell Biology, DOI: 10.1038/nrm3806).

Other names

Dermal extracellular collagen matrixSkin extracellular matrixCutaneous ECMDermal collagen matrixDermal matrix

Modulation of the dermal extracellular matrix occurs through the stimulation of collagen synthesis via fibroblast activation, the enzymatic degradation of collagen fibers by exogenous proteases, or the provision of physical scaffolds to support tissue regeneration and structural integrity.